Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Sorrento Therapeutics, Inc.
University of Colorado, Denver
Novartis
Medstar Health Research Institute
Brown University
University of California, San Francisco
University of Texas Southwestern Medical Center
Insel Gruppe AG, University Hospital Bern
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
The Methodist Hospital Research Institute
University of Arizona
M.D. Anderson Cancer Center
Medivation, Inc.
Genentech, Inc.
Rutgers, The State University of New Jersey
Loyola University
Fox Chase Cancer Center
AIDS Malignancy Consortium
Hoag Memorial Hospital Presbyterian
University of California, San Francisco